SPXV:ARCA-ProShares S&P 500 Ex-Health Care (USD)

ETF | Large Blend | NYSE Arca

Last Closing

USD 65.4569

Change

+0.06 (+0.09)%

Market Cap

USD 1.15M

Volume

848.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results, before fees and expenses that track the performance of the S&P 500? Ex-Health Care Index (the "index"). Under normal circumstances, the fund will invest at least 80% of its total assets in component securities. The index seeks to provide exposure to the companies of the S&P 500? Index (the "S&P 500?") with the exception of those companies included in the Health Care Sector.

Inception Date: 22/09/2015

Primary Benchmark: S&P 500 Ex-Health Care USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.27%

Management Expense Ratio: 0.27 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Large Blend

Symbol Name Mer Price(Change) Market Cap
VTI Vanguard Total Stock Market In.. 0.03 %

-3.22 (-1.08%)

USD 456.91B
SPLG SPDR® Portfolio S&P 500 ETF 0.04 %

-0.97 (-1.37%)

USD 54.47B
SCHX Schwab U.S. Large-Cap ETF 0.03 %

-0.27 (-1.13%)

USD 51.93B
DYNF BlackRock US Equity Factor Rot.. 0.00 %

-0.59 (-1.12%)

USD 14.33B
GSLC Goldman Sachs ActiveBeta® U.S.. 0.09 %

-1.17 (-0.99%)

USD 13.32B
SPTM SPDR® Portfolio S&P 1500 Comp.. 0.04 %

-0.77 (-1.05%)

USD 9.84B
SPLV Invesco S&P 500® Low Volatili.. 0.25 %

-0.33 (-0.47%)

USD 7.27B
JQUA JPMorgan U.S. Quality Factor E.. 0.12 %

-0.49 (-0.84%)

USD 5.38B
SCHK Schwab 1000 ETF 0.05 %

-0.31 (-1.07%)

USD 4.10B
SUSA iShares MSCI USA ESG Select 0.25 %

-1.34 (-1.07%)

USD 3.87B

ETFs Containing SPXV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Large Blend) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 30.10% 92% A 86% B+
Dividend Return 1.03% 48% F 15% F
Total Return 31.12% 93% A 85% B
Trailing 12 Months  
Capital Gain 29.60% 92% A 86% B+
Dividend Return 1.02% 48% F 15% F
Total Return 30.63% 93% A 85% B
Trailing 5 Years  
Capital Gain 94.09% 89% A- 86% B+
Dividend Return 9.11% 56% F 28% F
Total Return 103.20% 90% A- 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 14.25% 65% D 74% C
Dividend Return 15.58% 65% D 72% C
Total Return 1.33% 60% D- 33% F
Risk Return Profile  
Volatility (Standard Deviation) 21.50% 29% F 51% F
Risk Adjusted Return 72.46% 43% F 83% B
Market Capitalization 1.15M 10% F 14% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.